KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables Refunds
Ratios

BioNTech SE (BNTX) Receivables Refunds (2018 - 2025)

BioNTech SE's Receivables Refunds history spans 8 years, with the latest figure at $61.2 million for Q4 2025.

  • On a quarterly basis, Receivables Refunds rose 14.6% to $61.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.2 million, a 14.6% increase, with the full-year FY2025 number at $59.4 million, up 11.23% from a year prior.
  • Receivables Refunds hit $61.2 million in Q4 2025 for BioNTech SE, down from $99.1 million in the prior quarter.
  • Over the last five years, Receivables Refunds for BNTX hit a ceiling of $571.7 million in Q1 2023 and a floor of $403309.7 in Q3 2022.
  • Historically, Receivables Refunds has averaged $141.7 million across 5 years, with a median of $71.3 million in 2025.
  • Biggest five-year swings in Receivables Refunds: skyrocketed 127237.31% in 2023 and later plummeted 78.57% in 2025.
  • Tracing BNTX's Receivables Refunds over 5 years: stood at $457588.4 in 2021, then decreased by 10.82% to $408098.9 in 2022, then soared by 47119.15% to $192.7 million in 2023, then plummeted by 72.27% to $53.4 million in 2024, then grew by 14.6% to $61.2 million in 2025.
  • Business Quant data shows Receivables Refunds for BNTX at $61.2 million in Q4 2025, $99.1 million in Q3 2025, and $78.9 million in Q2 2025.